Triple A syndrome

Search Trials
Rare Disease Patient Registry & Natural History Study – Coordination of Rare Diseases at Sanford
Status:
Recruiting
Last Changed:
Dec 15, 2021
First Changed:
Feb 15, 2013
Disease(s):
Rare Disorders
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Sep 14, 2021
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4
Status:
Completed
Last Changed:
Apr 3, 2012
First Changed:
Aug 31, 2001
Disease(s):
HIV Infections
Intervention(s):
NevirapineZidovudineZalcitabineDidanosine
A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4
Status:
Completed
Last Changed:
Apr 3, 2012
First Changed:
Aug 31, 2001
Disease(s):
HIV Infections
Intervention(s):
NevirapineZidovudineZalcitabineDidanosine

Connect. Empower. Inspire.